ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Headache,Headaches NEC,Headaches,Nerv,N
1,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2,2,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
2,3,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2,4,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2,5,Cardiomegaly,Myocardial disorders NEC,Myocardial disorders,Card,N
2,6,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
2,7,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
2,8,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,Y
3,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
3,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
3,3,Meningococcal infection,Neisseria infections,Bacterial infectious disorders,Infec,N
4,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
4,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
5,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
5,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
5,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
5,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
5,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
6,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
7,1,Pre-eclampsia,Hypertension associated disorders of pregnancy,Maternal complications of pregnancy,Preg,N
8,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
8,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
8,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
8,4,Febrile infection,Infections NEC,Infections - pathogen unspecified,Infec,N
8,5,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
8,6,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
8,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
8,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
9,1,Meningococcal infection,Neisseria infections,Bacterial infectious disorders,Infec,N
9,2,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
10,1,Portal vein thrombosis,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,Y
11,1,Deafness transitory,Hearing losses,Hearing disorders,Ear,N
11,2,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
11,3,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
11,4,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
11,5,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
12,1,Escherichia urinary tract infection,Escherichia infections,Bacterial infectious disorders,Infec,N
12,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
12,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
12,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
13,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
13,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
13,3,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
13,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
14,1,H1N1 influenza,Influenza viral infections,Viral infectious disorders,Infec,N
15,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
16,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
16,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
17,1,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
18,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,Y
19,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
20,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
21,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
22,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
22,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
22,3,Pre-eclampsia,Hypertension associated disorders of pregnancy,Maternal complications of pregnancy,Preg,N
23,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
23,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
24,1,Gastrointestinal necrosis,Gastrointestinal necrosis and gangrene (excl gangrenous hernia),Gastrointestinal vascular conditions,Gastr,Y
24,2,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
24,3,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
24,4,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
24,5,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
25,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
25,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
25,3,Respiratory rate increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
25,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
26,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
26,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
27,1,Bedridden,Disability issues,Lifestyle issues,SocCi,N
27,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
27,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
27,4,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
27,5,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
27,6,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
28,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
28,2,Headache,Headaches NEC,Headaches,Nerv,N
28,3,Mouth injury,Abdominal and gastrointestinal injuries NEC,Injuries NEC,Inj&P,N
28,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
29,1,Meningococcal infection,Neisseria infections,Bacterial infectious disorders,Infec,N
29,2,Meningococcal sepsis,Neisseria infections,Bacterial infectious disorders,Infec,N
30,1,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,Y
31,1,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,Y
32,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
33,1,Arterial thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
33,2,Blood lactic acid increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
33,3,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
33,4,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
33,5,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
33,6,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
33,7,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
33,8,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
33,9,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
33,10,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
34,1,Exposure via breast milk,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
34,2,Foetal distress syndrome,Foetal complications NEC,Foetal complications,Preg,N
34,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
35,1,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
36,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
37,1,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
37,2,Hepatic vein thrombosis,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
37,3,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
37,4,Splenic vein thrombosis,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
38,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
39,1,Meningitis meningococcal,Neisseria infections,Bacterial infectious disorders,Infec,N
39,2,Meningococcal sepsis,Neisseria infections,Bacterial infectious disorders,Infec,N
39,3,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
40,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
40,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
40,3,Meningitis meningococcal,Neisseria infections,Bacterial infectious disorders,Infec,N
40,4,Meningococcal infection,Neisseria infections,Bacterial infectious disorders,Infec,N
40,5,Meningococcal sepsis,Neisseria infections,Bacterial infectious disorders,Infec,N
41,1,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
41,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
42,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
42,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
42,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
42,4,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
42,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
42,6,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
43,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
43,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
44,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
44,2,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
45,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
45,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
45,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
45,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
45,5,Middle insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
46,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
46,2,Lip haemorrhage,Oral soft tissue haemorrhages,Oral soft tissue conditions,Gastr,N
46,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
46,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
47,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
47,2,Cold type haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,Y
47,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
47,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
47,5,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
47,6,Eating disorder,Eating disorders NEC,Eating disorders and disturbances,Psych,N
48,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
49,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
49,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
49,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
49,4,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
49,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
49,6,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
49,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
50,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
50,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
50,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
51,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
51,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
52,1,Acute coronary syndrome,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
52,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
52,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
52,4,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
52,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
52,6,Paroxysmal nocturnal haemoglobinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
52,7,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
52,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
52,9,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
53,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
53,2,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
54,1,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
55,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
55,2,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
55,3,Headache,Headaches NEC,Headaches,Nerv,N
55,4,Ocular discomfort,Ocular disorders NEC,Eye disorders NEC,Eye,N
56,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
57,1,Budd-Chiari syndrome,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
57,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
58,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
58,2,Diabetic microangiopathy,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
58,3,Lacunar infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
58,4,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
59,1,Thrombotic cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
60,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
61,1,Bone marrow transplant,Haematological therapeutic procedures NEC,Haematological and lymphoid tissue therapeutic procedures,Surg,Y
62,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
63,1,Groin infection,Infections NEC,Infections - pathogen unspecified,Infec,N
63,2,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
63,3,Tongue ulceration,Tongue disorders,Tongue conditions,Gastr,N
63,4,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
64,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
64,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
64,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
64,4,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
64,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
65,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
65,2,Transfusion,Blood and blood product treatment,Haematological and lymphoid tissue therapeutic procedures,Surg,N
66,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
66,2,Hypovolaemic shock,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
67,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
68,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
68,2,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
68,3,Portal vein thrombosis,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
68,4,Retained placenta or membranes,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
68,5,Uterine haemorrhage,Uterine disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
69,1,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
70,1,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
70,2,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
71,1,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
72,1,Nephrectomy,Renal therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
72,2,Renal cortical necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
72,3,Renal haemangioma,Renal neoplasms benign,Renal and urinary tract neoplasms benign,Neopl,N
73,1,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,Y
74,1,Mycobacterium avium complex infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
75,1,Glomerulonephritis,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
76,1,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
77,1,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
78,1,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
79,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
79,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
80,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
80,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
80,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
80,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
81,1,Pre-eclampsia,Hypertension associated disorders of pregnancy,Maternal complications of pregnancy,Preg,N
81,2,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
82,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
82,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
82,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
83,1,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
83,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
83,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
84,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
85,1,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
86,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
87,1,Seronegative arthritis,Arthropathies NEC,Joint disorders,Musc,N
88,1,Blood product transfusion dependent,Disability issues,Lifestyle issues,SocCi,N
88,2,Congenital aplasia,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
88,3,Extravascular haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
89,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
90,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
90,2,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
91,1,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
91,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
91,3,Transfusion,Blood and blood product treatment,Haematological and lymphoid tissue therapeutic procedures,Surg,N
92,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
92,2,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
92,3,Hernia,Hernias NEC,General system disorders NEC,Genrl,N
92,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
92,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
92,6,Wound dehiscence,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
92,7,Wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
93,1,Extravascular haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
94,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
94,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
94,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
94,4,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
94,5,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
95,1,Varices oesophageal,Oesophageal varices,Gastrointestinal vascular conditions,Gastr,Y
96,1,Shunt occlusion,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
97,1,Headache,Headaches NEC,Headaches,Nerv,N
97,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
97,3,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
97,4,Vomiting projectile,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
98,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
98,2,Urine protein/creatinine ratio increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
99,1,Cholestasis of pregnancy,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
99,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
99,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
99,4,Oligohydramnios,Amniotic fluid and cavity disorders of pregnancy NEC,"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
99,5,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
99,6,Transfusion,Blood and blood product treatment,Haematological and lymphoid tissue therapeutic procedures,Surg,N
100,1,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
100,2,Laboratory test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
101,1,Blood lactate dehydrogenase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
101,2,Complement factor increased,Immune response protein analyses NEC,Immunology and allergy investigations,Inv,N
101,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
102,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
102,2,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
102,3,Blood lactate dehydrogenase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
102,4,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
102,5,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
103,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
103,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
104,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
105,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
106,1,Acute graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
107,1,Chronic graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
108,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
108,2,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
108,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
108,4,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
108,5,Red blood cell schistocytes present,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
108,6,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
109,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
110,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
111,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
112,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
113,1,Eosinophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
113,2,Monocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
113,3,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
113,4,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
114,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
115,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
115,2,Complement factor abnormal,Immune response protein analyses NEC,Immunology and allergy investigations,Inv,N
115,3,Laboratory test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
115,4,Microangiopathic haemolytic anaemia,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
115,5,Organ failure,General signs and symptoms NEC,General system disorders NEC,Genrl,N
115,6,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
115,7,Urethral stenosis,Structural and obstructive urethral disorders (excl congenital),Urethral disorders (excl calculi),Renal,N
116,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
117,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
117,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
118,1,Blood lactate dehydrogenase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
118,2,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
118,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
118,4,Haematology test abnormal,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
118,5,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
118,6,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
118,7,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
118,8,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
118,9,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
118,10,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
119,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
120,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
120,2,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,Y
121,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
122,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
122,2,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
123,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
123,2,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
124,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
124,2,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
125,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
125,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
125,3,Nephrectomy,Renal therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
125,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
125,5,Pleural fibrosis,Pleural conditions NEC,Pleural disorders,Resp,N
126,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
126,2,Blood lactate dehydrogenase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
127,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
127,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
127,3,Transfusion,Blood and blood product treatment,Haematological and lymphoid tissue therapeutic procedures,Surg,N
127,4,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
128,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
128,2,Engraft failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
128,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
128,4,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
129,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
130,1,Systemic candida,Candida infections,Fungal infectious disorders,Infec,N
131,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
131,2,Headache,Headaches NEC,Headaches,Nerv,N
131,3,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
131,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
131,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
131,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
132,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
133,1,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
134,1,BK virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
134,2,Blood lactate dehydrogenase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
134,3,Epstein-Barr viraemia,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
134,4,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
135,1,Gene mutation,Gene mutations and other alterations NEC,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
135,2,Pancreatitis chronic,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
136,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
137,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
138,1,Meningitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
139,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
140,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
141,1,Cerebral disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,Y
142,1,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
142,2,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
143,1,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
143,2,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
143,3,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
143,4,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
144,1,Meningitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
145,1,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,Y
145,2,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
146,1,Neuroblastoma,Nervous system neoplasms malignant NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
146,2,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
147,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
147,2,Foetal vascular malperfusion,Placental abnormalities (excl neoplasms),"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
147,3,Premature separation of placenta,Haemorrhagic complications of pregnancy,Maternal complications of pregnancy,Preg,N
148,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
148,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
149,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
149,2,Foetal malformation,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
150,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
150,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
151,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
151,2,Renal transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
152,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
152,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
152,3,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
153,1,Complications of transplanted heart,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,Y
153,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
153,3,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
154,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
155,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
156,1,Complications of transplanted kidney,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
156,2,Graft thrombosis,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
156,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
156,4,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
156,5,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
156,6,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
156,7,Thrombotic thrombocytopenic purpura,Thrombocytopenias,Platelet disorders,Blood,N
156,8,Transplant dysfunction,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
156,9,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
157,1,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
157,2,Device related infection,Infections NEC,Infections - pathogen unspecified,Infec,N
157,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
157,4,Graft loss,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
157,5,Klebsiella infection,Klebsiella infections,Bacterial infectious disorders,Infec,N
157,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
157,7,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
158,1,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
159,1,Meningococcal infection,Neisseria infections,Bacterial infectious disorders,Infec,N
159,2,Vaccination failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
160,1,Enterovirus infection,Enteroviral infections NEC,Viral infectious disorders,Infec,N
161,1,Bell's palsy,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
161,2,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
161,3,Enterovirus infection,Enteroviral infections NEC,Viral infectious disorders,Infec,N
161,4,Rales,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
162,1,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
163,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
164,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
164,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
164,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
164,4,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
164,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
164,6,Fracture pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
164,7,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
164,8,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
164,9,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
164,10,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
165,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
165,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
165,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
165,4,Cholecystitis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
165,5,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
165,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
165,7,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
165,8,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
165,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
166,1,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
167,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
167,2,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
167,3,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
167,4,Metapneumovirus infection,Viral infections NEC,Viral infectious disorders,Infec,N
167,5,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
167,6,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
168,1,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
168,2,Haemorrhagic transformation stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
168,3,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
168,4,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
168,5,Toxoplasmosis,Toxoplasma infections,Protozoal infectious disorders,Infec,N
169,1,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
170,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
170,2,Meningococcal infection,Neisseria infections,Bacterial infectious disorders,Infec,N
171,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
172,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
172,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
173,1,Meningitis meningococcal,Neisseria infections,Bacterial infectious disorders,Infec,N
174,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
175,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
176,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
176,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
176,3,Pre-eclampsia,Hypertension associated disorders of pregnancy,Maternal complications of pregnancy,Preg,N
177,1,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,Y
177,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
177,3,Foetal growth restriction,Foetal growth complications,Foetal complications,Preg,N
178,1,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
179,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
180,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
180,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
181,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
182,1,Blood lactate dehydrogenase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
182,2,Delayed graft function,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
182,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
182,4,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
182,5,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
182,6,Oliguria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
182,7,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
182,8,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
183,1,Multimorbidity,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
184,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
185,1,Arteriovenous fistula,Vascular malformations and acquired anomalies,Vascular disorders NEC,Vasc,N
185,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
185,3,Cardiovascular disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
185,4,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
185,5,Malignant hypertension,Accelerated and malignant hypertension,Vascular hypertensive disorders,Vasc,N
185,6,Nephritis,Nephritis NEC,Nephropathies,Renal,N
185,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
185,8,Post procedural complication,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
185,9,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
185,10,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
185,11,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
186,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
187,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
187,2,Hydronephrosis,Renal obstructive disorders,Renal disorders (excl nephropathies),Renal,N
187,3,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
187,4,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
187,5,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
188,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
188,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
188,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
188,4,Idiopathic pneumonia syndrome,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
188,5,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
188,6,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
188,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
188,8,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
188,9,Poor venous access,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
188,10,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
188,11,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
188,12,Weaning failure,Respiratory tract and thoracic cavity procedural complications,Procedural related injuries and complications NEC,Inj&P,N
189,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
190,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
190,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
191,1,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
191,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
191,3,Spinal fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
192,1,Arteriovenous fistula thrombosis,Cardiac and vascular procedural complications,Procedural related injuries and complications NEC,Inj&P,N
193,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
193,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
194,1,Arteriosclerosis,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
194,2,Glomerulosclerosis,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
194,3,Microangiopathy,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
194,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
194,5,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
194,6,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
195,1,Atypical mycobacterial infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
195,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
195,3,Haemodynamic instability,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
195,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
195,5,Idiopathic pneumonia syndrome,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
195,6,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
195,7,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
196,1,Meningococcal sepsis,Neisseria infections,Bacterial infectious disorders,Infec,N
196,2,Renal transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
197,1,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
197,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
197,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
197,4,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
197,5,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
197,6,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
197,7,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
197,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
198,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
199,1,Meningococcal infection,Neisseria infections,Bacterial infectious disorders,Infec,N
200,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
201,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
202,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
202,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
202,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
203,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
203,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
203,3,Foetal growth restriction,Foetal growth complications,Foetal complications,Preg,N
203,4,Intestinal dilatation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
203,5,Maternal exposure during breast feeding,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
203,6,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
204,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
204,2,Maternal exposure during breast feeding,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
204,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
205,1,Meningitis meningococcal,Neisseria infections,Bacterial infectious disorders,Infec,N
205,2,Meningococcal infection,Neisseria infections,Bacterial infectious disorders,Infec,N
205,3,Meningococcal sepsis,Neisseria infections,Bacterial infectious disorders,Infec,N
206,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
206,2,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
206,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
207,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
208,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
208,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
208,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
208,4,Meningitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
208,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
209,1,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
209,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
209,3,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
210,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
210,2,Transfusion,Blood and blood product treatment,Haematological and lymphoid tissue therapeutic procedures,Surg,N
211,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
211,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
212,1,Immune system disorder,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
212,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
213,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
213,2,Blood creatinine abnormal,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
213,3,Delayed engraftment,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
213,4,Fluid imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
213,5,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
213,6,Microangiopathy,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
213,7,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
213,8,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
213,9,Post procedural haematoma,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
213,10,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
213,11,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
213,12,Renal tubular acidosis,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
213,13,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
213,14,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
213,15,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
214,1,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
214,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
214,3,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
215,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
215,2,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
215,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
215,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
215,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
215,6,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
215,7,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
216,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
216,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
216,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
216,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
216,5,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
216,6,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
216,7,Transfusion,Blood and blood product treatment,Haematological and lymphoid tissue therapeutic procedures,Surg,N
217,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
217,2,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
217,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
217,4,Mean cell volume increased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
217,5,Neurological decompensation,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
218,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
218,2,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
219,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
219,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
219,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
219,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
220,1,Meningococcal sepsis,Neisseria infections,Bacterial infectious disorders,Infec,N
221,1,Meningococcal sepsis,Neisseria infections,Bacterial infectious disorders,Infec,N
222,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
222,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
222,3,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
222,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
222,5,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
222,6,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
223,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
223,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
224,1,Meningococcal infection,Neisseria infections,Bacterial infectious disorders,Infec,N
225,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
226,1,Meningococcal sepsis,Neisseria infections,Bacterial infectious disorders,Infec,N
227,1,Meningococcal infection,Neisseria infections,Bacterial infectious disorders,Infec,N
228,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
229,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
230,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
230,2,Headache,Headaches NEC,Headaches,Nerv,N
230,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
230,4,Meningococcal infection,Neisseria infections,Bacterial infectious disorders,Infec,N
230,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
230,6,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
230,7,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
230,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
230,9,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
231,1,Renal transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
232,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
233,1,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
234,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
234,2,Blood lactate dehydrogenase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
234,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
234,4,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
234,5,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
234,6,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
234,7,Metapneumovirus infection,Viral infections NEC,Viral infectious disorders,Infec,N
234,8,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
234,9,Platelet count abnormal,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
234,10,Red blood cell count decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
234,11,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
235,1,Meningococcal sepsis,Neisseria infections,Bacterial infectious disorders,Infec,N
236,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
237,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
237,2,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
237,3,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
237,4,Headache,Headaches NEC,Headaches,Nerv,N
237,5,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
238,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
238,2,Blood lactate dehydrogenase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
238,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
238,4,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
238,5,Haptoglobin abnormal,Haem metabolism analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
238,6,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
238,7,Nephrosclerosis,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
238,8,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
238,9,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
238,10,Renal vascular thrombosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
239,1,Meningococcal sepsis,Neisseria infections,Bacterial infectious disorders,Infec,N
240,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
241,1,Haemorrhagic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
242,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
243,1,Blood stem cell transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,Y
244,1,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,Y
244,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
245,1,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
246,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
247,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
247,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
247,3,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
247,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
248,1,Hepatic cancer,Hepatic neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,Y
248,2,Renal cancer metastatic,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
249,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
249,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
250,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
250,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
250,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
250,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
250,5,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
251,1,Cholecystitis acute,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
251,2,Pancreatitis necrotising,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
252,1,Cholecystitis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
253,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
253,2,Animal attack,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
253,3,Anuria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
253,4,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
253,5,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
253,6,Blood lactate dehydrogenase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
253,7,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
253,8,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
253,9,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
253,10,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
253,11,Haptoglobin decreased,Haem metabolism analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
253,12,Headache,Headaches NEC,Headaches,Nerv,N
253,13,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
253,14,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
254,1,Headache,Headaches NEC,Headaches,Nerv,N
254,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
254,3,Meningococcal bacteraemia,Neisseria infections,Bacterial infectious disorders,Infec,N
254,4,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
254,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
254,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
254,7,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
255,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
255,2,Headache,Headaches NEC,Headaches,Nerv,N
255,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
255,4,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
255,5,Neurological decompensation,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
255,6,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
255,7,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
255,8,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
255,9,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
255,10,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
256,1,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
256,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
257,1,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
257,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
257,3,Haemoglobin increased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
257,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
258,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
258,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
258,3,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
258,4,Quality of life decreased,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
259,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
259,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
259,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
259,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
259,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
260,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
260,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
261,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
261,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
261,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
262,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
262,2,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
263,1,Full blood count abnormal,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
263,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
264,1,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
265,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
265,2,Headache,Headaches NEC,Headaches,Nerv,N
265,3,Meningococcal infection,Neisseria infections,Bacterial infectious disorders,Infec,N
265,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
266,1,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
266,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
267,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
267,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
267,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
267,4,Retinal vein occlusion,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
267,5,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
267,6,Tracheostomy malfunction,Respiratory tract and thoracic cavity procedural complications,Procedural related injuries and complications NEC,Inj&P,N
268,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
268,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
268,3,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
269,1,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
270,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
271,1,Blood lactate dehydrogenase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
271,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
271,3,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
271,4,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
272,1,Clostridium difficile colitis,Clostridia infections,Bacterial infectious disorders,Infec,N
272,2,Device related infection,Infections NEC,Infections - pathogen unspecified,Infec,N
272,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
272,4,Urinary tract infection fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
273,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
274,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
274,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
274,3,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
275,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
276,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
277,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
278,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
278,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
278,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
279,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
279,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
280,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
281,1,Meningitis meningococcal,Neisseria infections,Bacterial infectious disorders,Infec,N
282,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
282,2,Pre-eclampsia,Hypertension associated disorders of pregnancy,Maternal complications of pregnancy,Preg,N
283,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
283,2,Cardiac flutter,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
283,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
283,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
284,1,Alopecia areata,Alopecias,Skin appendage conditions,Skin,N
284,2,Alopecia totalis,Alopecias,Skin appendage conditions,Skin,N
284,3,Eczema nummular,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
284,4,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,Y
284,5,Myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
284,6,Myelitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
284,7,Myelitis transverse,Myelitis (incl infective),Central nervous system infections and inflammations,Nerv,N
285,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
285,2,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,Y
285,3,Transfusion,Blood and blood product treatment,Haematological and lymphoid tissue therapeutic procedures,Surg,N
286,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
287,1,Meningitis meningococcal,Neisseria infections,Bacterial infectious disorders,Infec,N
287,2,Meningococcal sepsis,Neisseria infections,Bacterial infectious disorders,Infec,Y
288,1,Complement factor abnormal,Immune response protein analyses NEC,Immunology and allergy investigations,Inv,N
288,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
288,3,Renal transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
289,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
289,2,Duodenitis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
289,3,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
289,4,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
289,5,Tendonitis,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
290,1,Meningococcal sepsis,Neisseria infections,Bacterial infectious disorders,Infec,Y
291,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
291,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
291,3,Transfusion,Blood and blood product treatment,Haematological and lymphoid tissue therapeutic procedures,Surg,N
292,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
293,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
293,2,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,Y
293,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
294,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
294,2,Chromosome mapping abnormal,Chromosome analyses,Cytogenetic investigations and genetic analyses,Inv,N
294,3,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
295,1,Blood lactate dehydrogenase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
295,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
295,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
295,4,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
295,5,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
295,6,Pre-eclampsia,Hypertension associated disorders of pregnancy,Maternal complications of pregnancy,Preg,N
295,7,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
295,8,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
296,1,Blood lactate dehydrogenase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
296,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
296,3,Full blood count abnormal,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
296,4,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
296,5,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
296,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
296,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
296,8,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
296,9,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
297,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
297,2,Maternal exposure during breast feeding,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
297,3,Patent ductus arteriosus,Persistent foetal circulation disorders,Cardiac and vascular disorders congenital,Cong,N
298,1,Alloimmunisation,Blood isoimmune reactions,Immune disorders NEC,Immun,N
298,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
298,3,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
298,4,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
298,5,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
298,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
298,7,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
298,8,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
298,9,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
298,10,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
298,11,Sickle cell anaemia,Haemoglobinopathies congenital,Blood and lymphatic system disorders congenital,Cong,N
298,12,Sickle cell anaemia with crisis,Sickle cell trait and disorders,Haemoglobinopathies,Blood,N
298,13,Stupor,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
298,14,Stupor,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
298,15,Transfusion,Blood and blood product treatment,Haematological and lymphoid tissue therapeutic procedures,Surg,N
299,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
300,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
301,1,Meningitis meningococcal,Neisseria infections,Bacterial infectious disorders,Infec,N
302,1,Eye movement disorder,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
302,2,Muscle rigidity,Muscle tone abnormalities,Muscle disorders,Musc,N
302,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
302,4,Tonic clonic movements,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
303,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
304,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
304,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
304,3,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
304,4,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
304,5,Gastrointestinal infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
304,6,Haemodialysis,Renal therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
304,7,Immunodeficiency,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
304,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
304,9,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
304,10,Vein collapse,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
304,11,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
305,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
306,1,Cardiac valve disease,Cardiac valve disorders NEC,Cardiac valve disorders,Card,Y
306,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
307,1,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
307,2,Suspected COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
308,1,Blood creatine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
308,2,Delayed graft function,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
308,3,End stage renal disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
308,4,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
308,5,Renal transplant,Renal therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
308,6,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
309,1,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
309,2,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
309,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
309,4,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
310,1,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
310,2,Glomerular filtration rate increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
310,3,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
310,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
310,5,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
310,6,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
310,7,Urine albumin/creatinine ratio increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
311,1,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
311,2,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
311,3,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
312,1,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
312,2,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
312,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
312,4,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
313,1,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
313,2,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
313,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
313,4,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
314,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
314,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
315,1,Azotaemia,Renal failure complications,Renal disorders (excl nephropathies),Renal,N
315,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
315,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
316,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
317,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
317,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
317,3,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
318,1,Bone lesion,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
318,2,Infection reactivation,Infections NEC,Infections - pathogen unspecified,Infec,N
318,3,Latent tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
318,4,Mycobacterium tuberculosis complex test positive,Mycobacteria identification and serology,Microbiology and serology investigations,Inv,N
318,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
318,6,Pancreatic carcinoma metastatic,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,N
318,7,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
318,8,Tendon neoplasm,Soft tissue neoplasms malignant and unspecified NEC (excl sarcomas),Soft tissue neoplasms malignant and unspecified,Neopl,N
319,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
320,1,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
320,2,Blood lactate dehydrogenase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
320,3,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
320,4,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
320,5,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
320,6,Haemoglobinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
320,7,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
320,8,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
320,9,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
321,1,Antibiotic prophylaxis,Antiinfective therapies,Therapeutic procedures and supportive care NEC,Surg,N
321,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
321,3,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
321,4,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
322,1,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
322,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
323,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
323,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
323,3,Headache,Headaches NEC,Headaches,Nerv,N
323,4,Ileostomy,Small intestine therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
324,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
324,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
324,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
324,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
324,5,Poor venous access,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
324,6,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
324,7,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
325,1,Multimorbidity,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
326,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
326,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
326,3,Headache,Headaches NEC,Headaches,Nerv,N
326,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
326,5,Infusion site bruising,Infusion site reactions,Administration site reactions,Genrl,N
326,6,Renal pain,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
327,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
327,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
327,3,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
327,4,Irritable bowel syndrome,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
328,1,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
329,1,Headache,Headaches NEC,Headaches,Nerv,N
329,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
329,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
329,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
330,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
330,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
331,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
331,2,Near death experience,Perception disturbances NEC,Disturbances in thinking and perception,Psych,N
331,3,Poor venous access,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
332,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
332,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
332,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
332,4,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
332,5,Headache,Headaches NEC,Headaches,Nerv,N
332,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
332,7,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
332,8,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
332,9,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
332,10,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
333,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
333,2,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
333,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
333,4,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
333,5,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
333,6,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
333,7,Superficial inflammatory dermatosis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
333,8,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
333,9,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
334,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
334,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
334,3,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
334,4,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
334,5,Bone disorder,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
334,6,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
334,7,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
334,8,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
334,9,Choking,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
334,10,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
334,11,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
334,12,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
334,13,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
334,14,Gastrointestinal viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
334,15,Headache,Headaches NEC,Headaches,Nerv,N
334,16,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
334,17,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
334,18,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
334,19,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
334,20,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
334,21,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
334,22,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
334,23,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
334,24,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
334,25,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
334,26,Restless legs syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
334,27,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
334,28,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
334,29,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
334,30,Vulvovaginal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
335,1,Gastrointestinal carcinoma,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,Y
336,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
336,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
337,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
337,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
337,3,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
337,4,Endocarditis,Cardiac infections,Infections - pathogen unspecified,Infec,N
337,5,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
337,6,Lupus nephritis,Nephritis NEC,Nephropathies,Renal,N
337,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
337,8,Poor venous access,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
337,9,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
337,10,SARS-CoV-2 test negative,Virus identification and serology,Microbiology and serology investigations,Inv,N
338,1,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
338,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
338,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
338,4,Headache,Headaches NEC,Headaches,Nerv,N
338,5,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
339,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
339,2,Jaundice neonatal,Neonatal hepatobiliary disorders,Neonatal and perinatal conditions,Preg,N
340,1,Extravascular haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
341,1,Extravascular haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
341,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
342,1,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
342,2,Injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
343,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
344,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
344,2,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
344,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
344,4,Pre-eclampsia,Hypertension associated disorders of pregnancy,Maternal complications of pregnancy,Preg,N
345,1,Cytogenetic abnormality,Chromosomal abnormalities NEC,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
346,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
346,2,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
347,1,Breakthrough haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
348,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
349,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
349,2,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
349,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
349,4,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
350,1,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
351,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
352,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
353,1,Exposure via breast milk,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
353,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
354,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
354,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
354,3,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
355,1,Meningococcal infection,Neisseria infections,Bacterial infectious disorders,Infec,N
355,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
356,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
357,1,Central venous catheterisation,Venous therapeutic procedures,Vascular therapeutic procedures,Surg,N
357,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
357,3,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
357,4,Varicella,Herpes viral infections,Viral infectious disorders,Infec,N
358,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
358,2,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
359,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
360,1,Iron overload,Iron excess,Iron and trace metal metabolism disorders,Metab,N
360,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
360,3,Serum ferritin increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
361,1,Headache,Headaches NEC,Headaches,Nerv,N
361,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
361,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
361,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
361,5,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
362,1,Bradyarrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
363,1,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
363,2,Headache,Headaches NEC,Headaches,Nerv,N
363,3,Hip arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
364,1,Transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
364,2,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
364,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
365,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
365,2,Anuria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
365,3,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
365,4,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
365,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
365,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
365,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
365,8,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
366,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
366,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
366,3,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
366,4,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
367,1,Arthropod bite,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
367,2,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
367,3,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
367,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
368,1,Petit mal epilepsy,Absence seizures,Seizures (incl subtypes),Nerv,N
368,2,Tic,Tic disorders,Changes in physical activity,Psych,N
369,1,Hypertensive encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
369,2,Meningism,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
370,1,Renal cancer metastatic,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,Y
371,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
371,2,Intravascular haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
371,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
371,4,Warm autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
372,1,Atypical haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
372,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
372,3,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
372,4,Product deposit,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
373,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
373,2,Dialysis,Renal therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
373,3,Gene mutation,Gene mutations and other alterations NEC,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
373,4,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
374,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
374,2,Headache,Headaches NEC,Headaches,Nerv,N
375,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
375,2,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
375,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
375,4,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
376,1,Renal transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
377,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
377,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
377,3,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
378,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
379,1,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
380,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
380,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
381,1,Meningococcal sepsis,Neisseria infections,Bacterial infectious disorders,Infec,N
382,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
382,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
383,1,Extravascular haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
384,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
385,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
385,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
385,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
386,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
386,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
386,3,Transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
386,4,Urosepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
387,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
387,2,Suspected COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
388,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
389,1,Fear of injection,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
389,2,Poor venous access,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
390,1,Fear of injection,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
